February 20, 2026
Researchers from Insilico Medicine and Lilly Unveil Groundbreaking Vision for Fully Autonomous “Prompt-to-Drug” Pharmaceutical R&D in ACS Central Science
Indeterminate
Bioengineer.org
Owner:
Non-transparent